Africa-led cancer innovation company leveraging underrepresented genomic data to advance precision oncology globally.
Yemaachi Biotech pioneers clinical genomic research across Africa to advance precision oncology. The company collects and sequences biological samples from the most genetically diverse population on earth to build a first-of-its-kind cancer knowledgebase on African people. It partners with public, private, and non-profit organizations globally to diversify cancer diagnostics and therapeutics. Offices are in Ghana, USA, and Kenya. Yemaachi Biotech is a product of Yemaachi Biotechnology.